ストックスクリーナーアプリを入手
26.30
1.54%
0.40
Pfizer Inc (PFE) 最新ニュース
Pfizer Cuts Last AAV Gene Therapy Program By Taking Beqvez Off The Market - News & Insights
Pfizer Jettisons FDA-Approved Hemophilia B Gene Therapy Beqvez - CGTLive™
Cell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes - Yahoo Finance
Pfizer shelves haemophilia gene therapy Beqvez amid low demand - Yahoo Finance
Pfizer: Investors Won't Stick Around Forever (NYSE:PFE) - Seeking Alpha
Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’s new chair - BioPharma Dive
Pfizer stops selling hemophilia gene therapy, citing weak demand - BioPharma Dive
An awkward moment for Pfizer’s Bourla in Washington - STAT
Topical Drug Delivery Market Booming Innovations & Forecast 2032 with Johnson & Johnson, Pfizer Inc., GSK plc, - EIN News
Is Pfizer Inc. (PFE) the Best Non-Tech Stock to Buy Now for Long Term? - Insider Monkey
Capital Advisory Group Advisory Services LLC Makes New $292,000 Investment in Pfizer Inc. (NYSE:PFE) - MarketBeat
Bradley Foster & Sargent Inc. CT Purchases 139,215 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Health Rounds: Swabs as good as unpleasant speculum exam for detecting cancer-causing HPV - Marketscreener.com
Pfizer Inc. (NYSE:PFE) is WP Advisors LLC's 5th Largest Position - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Purchased by Kentucky Retirement Systems Insurance Trust Fund - MarketBeat
Compass Capital Corp MA ADV Buys Shares of 49,457 Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer stops commercialization of hemophilia gene therapy Beqvez - Reuters
ING Groep NV Boosts Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Ieq Capital LLC Purchases 40,117 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Bryn Mawr Capital Management LLC - MarketBeat
#Pfizer has announced a strategic marketing and supply agreement with Mylan Pharmaceuticals. The deal aims to bolster distribution and sales of its two well-known brands, Ativan and Pacitane, in India. #Pharmaceuticals - linkedin
Sanctuary Advisors LLC Cuts Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Ataxia Market Future Business Opportunities 2025-2032 | Pfizer, Inc., CRISPR Therapeutics, Acorda Therapeutics - openPR
Principal Financial Group Inc. Has $169.90 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Trading Up 0%Still a Buy? - MarketBeat
Pfizer says it will end global development of hemophilia gene therapy Beqvez - TradingView
Pfizer nixes Roche-partnered hemophilia drug (PFE:NYSE) - Seeking Alpha
Pfizer says it will end global development of gene therapy Beqvez, Nikkei reports -February 20, 2025 at 02:58 pm EST - Marketscreener.com
Pfizer halts work on hemophilia gene therapy - Nikkei Asia
Pfizer (NYSE:PFE) Shares Up 0.1%Here's What Happened - MarketBeat
Pfizer's Big Game Ad Wins LinkedIn Member Poll - Pfizer
What's Driving the Market Sentiment Around Pfizer? - Benzinga
U.S. Diabetic Neuropathy Market to Witness Stunning Growth with Eli Lilly & Company, Johnson & Johnson - EIN News
Boston Financial Mangement LLC Increases Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
14,772 Shares in Pfizer Inc. (NYSE:PFE) Purchased by Advyzon Investment Management LLC - MarketBeat
First Bank & Trust Has $1.76 Million Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Davidson Investment Advisors Sells 100,344 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Handelsbanken Fonder AB Has $64.14 Million Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Private Wealth Partners LLC Raises Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Cumberland Partners Ltd Acquires Shares of 76,600 Pfizer Inc. (NYSE:PFE) - MarketBeat
Private Advisor Group LLC Reduces Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Global Retirement Partners LLC Sells 24,744 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Vasopressin Market Is Booming Worldwide 2025-2032 | Par - openPR
Callahan Advisors LLC Purchases 69,155 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board of Directors for Breach of Fiduciary Duties (PFE) - TradingView
Trump to meet pharma leaders as they seek drug policy changes - Reuters
Pfizer (NYSE:PFE) Stock Price Down 0.6%Here's Why - MarketBeat
Pfizer (NYSE:PFE) Trading Up 0.9%Still a Buy? - MarketBeat
Pfizer (NYSE:PFE) Shares Up 0.1% on Insider Buying Activity - MarketBeat
TigerOak Management L.L.C. Purchases New Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Keene & Associates Inc. Has $2.52 Million Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Why Pfizer’s Stock Price Isn’t Reflecting Its True Value (NYSE:PFE) - Seeking Alpha
Bigelow Investment Advisors LLC Lowers Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Acquired by Hourglass Capital LLC - MarketBeat
Convergence Investment Partners LLC Buys 93,533 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
New York State Common Retirement Fund Reduces Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Bank of Jackson Hole Trust Makes New $264,000 Investment in Pfizer Inc. (NYSE:PFE) - MarketBeat
Medical Accompaniment Service Market Projected To Witness Substantial Growth, 2025-2032: Pfizer Inc., Bharat - EIN News
Pfizer Stock's Upside Got Bigger (NYSE:PFE) - Seeking Alpha
Pfizer (NYSE:PFE) Shares Down 0.6%What's Next? - MarketBeat
Hedge Fund and Insider Trading News: David Tepper, Ken Griffin, Paul Singer, Israel Englander, Typhon Capital Management, Palliser Capital, Pfizer Inc (PFE), and More - Insider Monkey
Pfizer (NYSE:PFE) Shares Up 0%Time to Buy? - MarketBeat
175 Days of Good - Pfizer
Pfizer Vulnerable to Threat of European Tariffs, CEO Says - MSN
Pfizer Inc. (PFE): Among the Best Very Cheap Stocks to Buy Right Now - Insider Monkey
0.07%
0.61%
大文字化:
|
ボリューム (24 時間):